1-3 of 3
S Yoshida
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Oral HDAC Inhibitor HBI8000 in Japanese Patients with Non-Hodgkin Lymphoma (NHL): Phase I Safety and Efficacy Results

Makoto Onizuka, MD PhD, Kiyoshi Ando, MD PhD, Makoto Yoshimitsu, MD, PhD, Takashi Ishida, MD PhD, S Yoshida, MD, Ilseung Choi, MD, Michihiro Hidaka, MD, Yasushi Takamatsu, MD PhD, Midori Nagashima, Akira Miyazato, MD PhD, Joachim P Schupp, MD, Alain Rolland, PharmD, PhD, Mireille Gillings, PhD, Gloria T. Lee, MD PhD, Kensei Tobinai, MD PhD
Journal: Blood
Blood (2016) 128 (22): 1827.
https://doi.org/10.1182/blood.V128.22.1827.1827
Published: 2016
Journal Articles

Lack of relationship between soluble erythropoietin receptor levels and erythroid parameters in anemic patients [letter; comment]

S Yoshida, M Bessho, K Sakate, I Hirasawa, M Murayoshi, K Hirashima
Journal: Blood
Blood (1996) 88 (8): 3246–3247.
https://doi.org/10.1182/blood.V88.8.3246.bloodjournal8883246
Published: 1996
Journal Articles

Aphidicolin, an inhibitor of DNA replication, blocks the TPA-induced differentiation of a human megakaryoblastic cell line, MEG-O1

T Murate, T Hotta, K Tsushita, M Suzuki, T Yoshida, S Saga, H Saito, S Yoshida
Journal: Blood
Blood (1991) 78 (12): 3168–3177.
https://doi.org/10.1182/blood.V78.12.3168.3168
Published: 1991